Adverse drug reactions and complaints

Reporting of adverse drug reactions

Reporting suspected adverse drug reactions to Novartis medicines is a key step in ensuring the safety of medicines and patients.

Why report suspected adverse drug reactions?

Patient safety and the safety of medicines are of paramount importance to Novartis. Even after a medicine is already available on the market, the safety profile of a medicine is constantly changing and being updated. Reports of suspected adverse drug reactions play an important role in this, as they help Novartis and the competent authorities to more accurately identify potential risks and take appropriate action.

How do you report a suspected adverse drug reaction?

If you notice a suspected adverse drug reaction while taking a Novartis medicine, please consult your doctor, pharmacist or other healthcare professional. You can also report a suspected adverse drug reaction directly to the National centre for pharmacovigilance according to the instructions published on the JAZMP website.

You can also report a suspected adverse drug reaction directly to Novartis, via the link or by e-mail to [email protected].

Reporting Product Complaints

Product complaints related to Novartis medicines must be reported in a timely manner to enable Novartis to assess potential issues related to product quality and, where necessary, to implement appropriate follow-up actions to ensure the continued safety, quality, and efficacy of the medicinal product.

How to Report a Product Complaint

Any product complaint or dissatisfaction related to a Novartis product (for example, quality, safety, performance, or use) should be reported by email to: [email protected].